Clinical prediction scores and early anticoagulation therapy for new-onset atrial fibrillation in critical illness: a post-hoc analysis

Autor: Masaaki Sakuraya, Takuo Yoshida, Yusuke Sasabuchi, Shodai Yoshihiro, Shigehiko Uchino

Publikováno v: BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-10 (2021)

Abstract Purpose This study sought to describe the epidemiology of anticoagulation therapy for critically ill patients with new-onset atrial fibrillation (NOAF) according to CHA2DS2-VASc and HAS-BLED scores and to assess the efficacy of early anticoa

Externí odkaz: https://doaj.org/article/b84ede5223f548afbcfe7ffe92957363

Rhythm-control therapy for new-onset atrial fibrillation in critically ill patients: A post hoc analysis from the prospective multicenter observational AFTER-ICU study

Autor: Takuo Yoshida, Shigehiko Uchino, Yusuke Sasabuchi, Michihito Kyo, Takashi Igarashi, Haruka Inoue

Publikováno v: International Journal of Cardiology: Heart & Vasculature, Vol 33, Iss , Pp 100742- (2021)

Background: Sustained new-onset atrial fibrillation (AF) in the intensive care unit has been reported to be associated with poor outcomes. However, in critical illness, whether rhythm-control therapy can achieve sinus rhythm (SR) restoration is unkno

Externí odkaz: https://doaj.org/article/2c924997ac2b4dc6a1df73b6f1d895ac

The RACE to the EAST. In pursuit of rhythm control therapy for atrial fibrillation-a dedication to Harry Crijns

Autor: A. John Camm, Andreas Metzner, Isabelle C. Van Gelder, Paulus Kirchhof, Günter Breithardt, Bruno Reissmann

Publikováno v: Europace, 23(2), 34-39. Oxford University Press
Europace

The RACE trial was one of the first landmark trials to establish whether restoring and maintaining sinus rhythm could reduce morbidity and mortality in patients with atrial fibrillation (AF). Its neutral outcome shaped clinical decision-making for al

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::016131b8dfeccf959268498b8bf68fcd
https://research.rug.nl/en/publications/1bc5f101-7b07-43b0-84f3-0ddf941eb595

Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial

Autor: Andreas Goette, Lars Eckardt, Hein Heidbuchel, Günter Breithardt, Anna Suling, Lukasz Szumowski, Laurent M. Haegeli, Isabelle C. Van Gelder, Karl-Heinz Kuck, A. John Camm, Stephan Willems, Paulus Kirchhof, Sakis Themistoclakis, Panos E. Vardas, Arif Elvan, Axel Brandes, Harry J.G.M. Crijns, Karl Wegscheider, Luis Mont, A Andre Ng, Andreas Metzner, Josef Kautzner

Publikováno v: Europace
EP Europace, 24(4), 552-564. Oxford University Press
Europace, 24(4). Oxford University Press
Metzner, A, Suling, A, Brandes, A, Breithardt, G, Camm, A J, Crijns, H J G M, Eckardt, L, Elvan, A, Goette, A, Haegeli, L M, Heidbuchel, H, Kautzner, J, Kuck, K-H, Mont, L, Ng, A A, Szumowski, L, Themistoclakis, S, van Gelder, I C, Vardas, P, Wegscheider, K, Willems, S & Kirchhof, P 2022, ' Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy : a detailed analysis of treatment patterns in the EAST-AFNET 4 trial ', Europace, vol. 24, no. 4, pp. 552-564 . https://doi.org/10.1093/europace/euab200
EP Europace

Aims Treatment patterns were compared between randomized groups in EAST-AFNET 4 to assess whether differences in anticoagulation, therapy of concomitant diseases, or intensity of care can explain the clinical benefit achieved with early rhythm contro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49ca539d7cd7e69390ab02cf5390c12a
https://pubmed.ncbi.nlm.nih.gov/34897422

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.